Actualité
Il y a 1 mois
Trois nouvelles découvertes - Sous les pavés, des plages inédites
Dire que les archives en tout genre du jazz regorgent de trésors est un euphémisme. Trois nouvelles découvertes.
Quotidien du médecin
Découvrez plus sur le même flux
Actualité
Actualité
Il y a 20 heures
Un cas de démence sur trois pourrait être évité
Quotidien du médecin
Articles liés par le même flux
Actualité
Qualité de vie au travail : des aides-soignantes en grève depuis 3 mois
Il y a 14 minutes
Espace Infirmier

Une dizaine d’aides-soignantes de l’Ehpad Les Opalines, à Foucherans, dans le Jura, sont en grève depuis le 3 avril dernier. Objectif : dénoncer leur condition de travail et réclamer des postes supplémentaires.

Actualité
Il y a 52 minutes
CHU Rouen

Les directives anticipées (DA) sont des documents écrits permettant à toute personne majeure d'exprimer sa volonté, dans le cas où elle serait un jour en incapacité de le faire. L'enjeu principal des DA est de préserver l'autonomie du patient dans ses décisions de fin de vie. L'obj[...]

Actualité
Il y a 52 minutes
CHU Rouen

Selon les pays, il existe différents systèmes permettant aux professionnels de santé et aux patients de déclarer les effets indésirables des médicaments. L'objectif de l'étude était de comprendre comment les patients identifiaient un effet indésirable, leurs réacti[...]

Actualité
Il y a 54 minutes
EFSA

Published on: 21 July 2017

Following an application from Loc Troi group, submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of the Netherlands, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to Vibigaba (germinated brown rice) and maintenance of long-term normal blood glucose concentration. The scope of the application was proposed to fall under a health claim based on newly developed scientific evidence. The food proposed by the applicant as the subject of the health claim is Vibigaba. The Panel considers that the germinated brown rice Vibigaba is sufficiently characterised. The claimed effect proposed by the applicant is ‘contribution to the maintenance of normal glycated haemoglobin level’. The Panel considers that maintenance of long-term normal blood glucose concentration is a beneficial physiological effect. The Panel notes that the applicant did not perform a comprehensive literature search to identify human intervention studies whic[...]

Actualité
Il y a 54 minutes
EFSA

Published on: 21 July 2017

Following an application from Loc Troi group, submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of the Netherlands, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to Vibigaba (germinated brown rice) and reduction of body weight in the context of an energy-restricted diet. The scope of the application was proposed to fall under a health claim based on newly developed scientific evidence. The food proposed by the applicant as the subject of the health claim is Vibigaba. The Panel considers that the germinated brown rice Vibigaba is sufficiently characterised. The claimed effect proposed by the applicant is ‘in the context of an energy-restricted diet contributes to weight loss’. The Panel considers that reduction of body weight in the context of an energy-restricted diet is a beneficial physiological effect. The Panel notes that the applicant did not perform a comprehensive literature searc[...]

Actualité
Il y a 54 minutes
EFSA

Published on: 21 July 2017

Following an application from Loc Troi group, submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of the Netherlands, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to Vibigaba (germinated brown rice) and contribution to the maintenance of normal blood pressure. The scope of the application was proposed to fall under a health claim based on newly developed scientific evidence. The food proposed by the applicant as the subject of the health claim is Vibigaba. The Panel considers that the germinated brown rice Vibigaba is sufficiently characterised. The claimed effect proposed by the applicant is ‘contribution to the maintenance of normal blood pressure’. The Panel considers that maintenance of normal blood pressure is a beneficial physiological effect. The Panel notes that the applicant did not perform a comprehensive literature search to identify human intervention studies [...]